最新报道:Australian pharmaceutical firm MYX faces scrutiny over a potential Sybil attack on its $170 million airdrop initiative aimed at boosting engagement on its digital health platform. The alleged network manipulation could undermine the credibility of the token distribution and impact investor sentiment. MYX, known for products like NEXTSTELLIS and ANNOVERA, has yet to comment on the claims as industry observers monitor the situation closely.